Xconomy | Seattle - Business + Technology in the Exponential Economy

Biotech, deals, National Institutes of Health

Insilicos Nabs $900K Grant From NIH

Luke Timmerman 12/18/08

Insilicos, a Seattle-based company that makes software for drug researchers, said today it has won a $900,000 grant from the National Institutes of Health. The money will be used to study “ensemble learning,” which uses a blend of statistical models to make a more accurate prediction about a biological experiment than a single model. Insilicos is also working on improving diagnostic tests for cardiovascular disease.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.


Links to This Post

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.